NIH-funded research P01 program project

Understanding how intestinal fungi affect autoimmune diseases

Official title: Gnotobiotic Core

Funded at Sloan-Kettering Inst Can Research · NIH-11061763 · Data updated 2026-11-12

This study is looking at how certain fungi in the gut, especially Candida, might be linked to autoimmune and inflammatory diseases, using special germ-free mice to see how these fungi behave and interact with the immune system, which could help us find new ways to treat these conditions.

Quick facts

Grant typeP01 program project
Study typeNIH-funded research
Funding institutionSloan-Kettering Inst Can Research
NIH-funded
Lab location1 site (New York, United States)
Project startApril 1, 2024
Project endMarch 31, 2029
Funding year2025
Award (this year)$295,590
NIH project number5P01AI179406-02
Project IDNIH-11061763 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from autoimmune conditions or inflammatory diseases related to gut health.

Less likely to help

Patients with non-autoimmune conditions or those not affected by gut microbiome issues may not benefit from this research.

What this research studies

This research investigates the role of intestinal fungi, particularly Candida species, in triggering autoimmune and inflammatory diseases. By using gnotobiotic mouse models, which are germ-free mice, the researchers will explore how these fungi colonize the intestine and the factors that influence their behavior. The study aims to manipulate various bacterial and fungal species in controlled environments to better understand their interactions with the host immune system. This approach could reveal critical insights into the mechanisms behind autoimmunity and inform potential therapeutic strategies.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for autoimmune diseases by targeting the interactions between intestinal fungi and the immune system.

How similar studies have gone: Previous research has shown promising results in understanding the role of the microbiome in autoimmune diseases, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Sloan-Kettering Inst Can Research
    New York, United States
    Active

Researchers

  • Principal investigator: Hohl, Tobias M — Sloan-Kettering Inst Can Research
  • Study coordinator: Hohl, Tobias M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.